<VariationArchive VariationID="2154" VariationName="NM_001127649.3(PEX26):c.34dup (p.Leu12fs)" VariationType="Duplication" Accession="VCV000002154" Version="21" RecordType="classified" NumberOfSubmissions="11" NumberOfSubmitters="10" DateLastUpdated="2024-07-29" DateCreated="2015-10-11" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17193" VariationID="2154">
      <GeneList>
        <Gene Symbol="PEX26" FullName="peroxisomal biogenesis factor 26" GeneID="55670" HGNC_ID="HGNC:22965" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="18077990" stop="18105396" display_start="18077990" display_stop="18105396" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="18560685" stop="18573796" display_start="18560685" display_stop="18573796" Strand="+" />
          </Location>
          <OMIM>608666</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001127649.3(PEX26):c.34dup (p.Leu12fs)</Name>
      <CanonicalSPDI>NC_000022.11:18078404:CCCCCC:CCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>22q11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="18078404" stop="18078405" display_start="18078404" display_stop="18078405" variantLength="1" positionVCF="18078404" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="18561170" stop="18561171" display_start="18561170" display_stop="18561171" variantLength="1" positionVCF="18561170" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>L12fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017929.5" sequenceAccession="NM_017929" sequenceVersion="5" change="c.34dupC">
            <Expression>NM_017929.5:c.34dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017929.5" sequenceAccession="NM_017929" sequenceVersion="5" change="c.29dupC">
            <Expression>NM_017929.5:c.29dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.18561176dup" Assembly="GRCh37">
            <Expression>NC_000022.10:g.18561176dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.18078410dup" Assembly="GRCh38">
            <Expression>NC_000022.11:g.18078410dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008339.1" sequenceAccession="NG_008339" sequenceVersion="1" change="g.5491dup">
            <Expression>NG_008339.1:g.5491dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008339.2" sequenceAccession="NG_008339" sequenceVersion="2" change="g.5422dup">
            <Expression>NG_008339.2:g.5422dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_201355.1" sequenceAccession="NG_201355" sequenceVersion="1" change="g.157dup">
            <Expression>NG_201355.1:g.157dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127649.3" sequenceAccession="NM_001127649" sequenceVersion="3" change="c.34dup" MANESelect="true">
            <Expression>NM_001127649.3:c.34dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121121.1" sequenceAccession="NP_001121121" sequenceVersion="1" change="p.Leu12fs">
            <Expression>NP_001121121.1:p.Leu12fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001199319.2" sequenceAccession="NM_001199319" sequenceVersion="2" change="c.34dup">
            <Expression>NM_001199319.2:c.34dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001186248.1" sequenceAccession="NP_001186248" sequenceVersion="1" change="p.Leu12fs">
            <Expression>NP_001186248.1:p.Leu12fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017929.6" sequenceAccession="NM_017929" sequenceVersion="6" change="c.34dup">
            <Expression>NM_017929.6:c.34dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060399.1" sequenceAccession="NP_060399" sequenceVersion="1" change="p.Leu12fs">
            <Expression>NP_060399.1:p.Leu12fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Interpreted" ID="2155" DB="ClinVar" />
        <XRef ID="CA115371" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="608666.0003" DB="OMIM" />
        <XRef Type="Allelic variant" ID="608666.0004" DB="OMIM" />
        <XRef Type="rs" ID="61752129" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001127649.3(PEX26):c.34dup (p.Leu12fs) AND Peroxisome biogenesis disorder 7A (Zellweger)" Accession="RCV000002237" Version="8">
        <ClassifiedConditionList TraitSetID="8956">
          <ClassifiedCondition DB="MedGen" ID="C3888385">Peroxisome biogenesis disorder 7A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-19" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001127649.3(PEX26):c.34dup (p.Leu12fs) AND Peroxisome biogenesis disorder 7B" Accession="RCV000662021" Version="6">
        <ClassifiedConditionList TraitSetID="8957">
          <ClassifiedCondition DB="MedGen" ID="C3553951">Peroxisome biogenesis disorder 7B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2018-12-05" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001127649.3(PEX26):c.34dup (p.Leu12fs) AND not provided" Accession="RCV000727235" Version="10">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-05-14" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001127649.3(PEX26):c.34dup (p.Leu12fs) AND Peroxisome biogenesis disorder" Accession="RCV000780590" Version="1">
        <ClassifiedConditionList TraitSetID="7944">
          <ClassifiedCondition DB="MedGen" ID="C1832200">Peroxisome biogenesis disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-10-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001127649.3(PEX26):c.34dup (p.Leu12fs) AND multiple conditions" Accession="RCV000821185" Version="3">
        <ClassifiedConditionList TraitSetID="10245">
          <ClassifiedCondition DB="MedGen" ID="C3888385">Peroxisome biogenesis disorder 7A (Zellweger)</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3553951">Peroxisome biogenesis disorder 7B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-19" NumberOfSubmissions="11" NumberOfSubmitters="10" DateCreated="2015-10-11" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12851857</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16257970</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19877282</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21031596</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PEX26</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="7944" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5752" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder</ElementValue>
                <XRef ID="INHP_50" DB="Ege University Pediatric Genetics, Ege University" />
                <XRef ID="MONDO:0019234" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS214100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER (NALD/IRD)</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PEROXISOME BIOGENESIS DISORDER (NEONATAL ADRENOLEUKODYSTROPHY/INFANTILE REFSUM DISEASE)</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INFANTILE PHYTANIC ACID STORAGE DISEASE</ElementValue>
                <XRef Type="MIM" ID="601539" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorders, Zellweger syndrome spectrum</ElementValue>
                <XRef ID="Peroxisome+biogenesis+disorders/5684" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALD: Adrenoleukodystrophy, X-Linked</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBDS</ElementValue>
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PBD, ZSS</ElementValue>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11890" />
                <XRef ID="11890" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000028503" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501632" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525961" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501473" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501644" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520399" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501628" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501626" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318883" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501635" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318975" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028499" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501631" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501629" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318886" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501633" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000593050" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501474" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000070509" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000004880" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000070507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501472" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501630" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592488" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501647" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501625" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501466" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301621</ID>
                <ID Source="BookShelf">NBK1448</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated lysophosphatidylcholines, X-Linked Adrenoleukodystrophy (X-ALD), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, X-ALD: Elevated lysophosphatidylcholines C24:0, C26:0, 2023</CitationText>
              </Citation>
              <XRef ID="79189" DB="Orphanet" />
              <XRef ID="C1832200" DB="MedGen" />
              <XRef ID="MONDO:0019234" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS214100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10245" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17437" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 7B</ElementValue>
                <XRef ID="MONDO:0013939" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PBD7B</ElementValue>
                <XRef Type="MIM" ID="614873" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15867" />
                <XRef ID="15867" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum (ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment. Children with the NALD presentation may reach their teens, and those with the IRD presentation may reach adulthood (summary by Waterham and Ebberink, 2012).
For a complete phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD), see 601539.
Individuals with mutations in the PEX26 gene have cells of complementation group 8 (CG8, equivalent to CGA). For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614873" DB="OMIM" />
              </AttributeSet>
              <XRef ID="44" DB="Orphanet" />
              <XRef ID="C3553951" DB="MedGen" />
              <XRef ID="MONDO:0013939" DB="MONDO" />
              <XRef Type="MIM" ID="614873" DB="OMIM" />
            </Trait>
            <Trait ID="17436" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 7A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013938" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 7A</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD7A</ElementValue>
                <XRef ID="GTR000522755" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614872" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15866" />
                <XRef ID="15866" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 8 (CG8, equivalent to CGA) have mutations in the PEX26 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614872" DB="OMIM" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3888385" DB="MedGen" />
              <XRef ID="MONDO:0013938" DB="MONDO" />
              <XRef Type="MIM" ID="614872" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8956" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17436" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 7A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013938" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 7A</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD7A</ElementValue>
                <XRef ID="GTR000522755" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614872" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15866" />
                <XRef ID="15866" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 8 (CG8, equivalent to CGA) have mutations in the PEX26 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614872" DB="OMIM" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3888385" DB="MedGen" />
              <XRef ID="MONDO:0013938" DB="MONDO" />
              <XRef Type="MIM" ID="614872" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8957" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17437" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 7B</ElementValue>
                <XRef ID="MONDO:0013939" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PBD7B</ElementValue>
                <XRef Type="MIM" ID="614873" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15867" />
                <XRef ID="15867" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum (ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment. Children with the NALD presentation may reach their teens, and those with the IRD presentation may reach adulthood (summary by Waterham and Ebberink, 2012).
For a complete phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD), see 601539.
Individuals with mutations in the PEX26 gene have cells of complementation group 8 (CG8, equivalent to CGA). For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614873" DB="OMIM" />
              </AttributeSet>
              <XRef ID="44" DB="Orphanet" />
              <XRef ID="C3553951" DB="MedGen" />
              <XRef ID="MONDO:0013939" DB="MONDO" />
              <XRef Type="MIM" ID="614873" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="22395" SubmissionDate="2017-02-06" DateLastUpdated="2015-10-11" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608666.0003_PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)" title="PEX26, 1-BP INS, 35C_PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)" />
        <ClinVarAccession Accession="SCV000022395" DateUpdated="2015-10-11" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient (cell line GM07371) with Zellweger syndrome (PBD7A; 614872), Matsumoto et al. (2003) identified compound heterozygosity for mutations in the PEX26 gene: one allele carried a homozygous 1-bp insertion, T35insC, that resulted in a frameshift introducing a 102-amino acid sequence distinct from normal PEX26, and the other allele carried the T35insC mutation as well as a 147-bp deletion of nucleotides 668-814 resulting in deletion of amino acids 223-271 (del223-271). Functional expression studies of the 35insC mutation showed almost normal catalase and thiolase import. Coexpression studies of the complex allele showed weak temperature-sensitive (30 degree C) import of catalase.</Attribute>
              <Citation>
                <ID Source="PubMed">12851857</ID>
              </Citation>
              <XRef DB="OMIM" ID="614872" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX26" />
          </GeneList>
          <Name>PEX26, 1-BP INS, 35C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 35C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608666.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1748190" SubmissionDate="2020-03-09" DateLastUpdated="2018-07-29" DateCreated="2018-07-29">
        <ClinVarSubmissionID localKey="22:18561176:C" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000891762" DateUpdated="2018-07-29" DateCreated="2018-07-29" Type="SCV" Version="1" SubmitterName="HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology" OrgID="505530" OrganizationCategory="laboratory" OrgAbbreviation="HA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG codes: PVS1, PM2, PP4, PP5</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">22:18561176:C:UAB00042P</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Oligohydramnios</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001562" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Micrognathia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000347" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of the face</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000271" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Wide anterior fontanel</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000260" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Large posterior fontanelle</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0004491" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Abnormal eye morphology</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0012372" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Hypertelorism</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000316" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Micrognathia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000347" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Redundant neck skin</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0005989" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Low-set ears</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000369" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Lissencephaly</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001339" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Abnormality of brain morphology</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0012443" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Seizures</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Talipes equinovarus</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001762" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX26" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017929.6:c.34dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614872" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-SouthSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB4848948</SubmissionName>
          <SubmissionName>SUB6903323</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2697801" SubmissionDate="2020-11-24" DateLastUpdated="2020-12-12" DateCreated="2020-07-04">
        <ClinVarSubmissionID localKey="NM_001127649.2:c.34dupC|OMIM:614873" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001369715" DateUpdated="2020-12-12" DateCreated="2020-07-04" Type="SCV" Version="2" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PP5.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001127649.2:c.34dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614873" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8622351</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3966167" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="ff5f6dc96df008fae84feb52a2b0fc7391df8126e1bda0c81871869f9525acec|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002016586" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-07-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017929.5:c.34dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1856269" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="2447825|MedGen:C3539168;C3553951" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000961934" DateUpdated="2024-02-28" DateCreated="2019-08-14" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12851857</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21031596</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12851857</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu12Profs*103) in the PEX26 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX26 are known to be pathogenic (PMID: 12851857, 21031596). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with Zellweger syndrome (PMID: 12851857). This variant is also known as T35insC. ClinVar contains an entry for this variant (Variation ID: 2154). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX26" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.18561170_18561171insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3539168" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553951" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1379241" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-16" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="60251_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000706843" DateUpdated="2018-12-16" DateCreated="2015-10-11" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX26" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="22" alternateAllele="CC" referenceAllele="C" start="18561176" stop="18561176" variantLength="1" />
            <GeneLocation>NM_017929.5:Ex2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CI032159" />
            <XRef DB="dbSNP" ID="757146419" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PEX26</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1794602" SubmissionDate="2019-04-24" DateLastUpdated="2019-06-02" DateCreated="2019-06-02">
        <ClinVarSubmissionID localKey="NM_017929.5:c.34dupC|MedGen:C1832200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000917987" DateUpdated="2019-06-02" DateCreated="2019-06-02" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19877282</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16257970</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12851857</ID>
          </Citation>
          <Comment>Variant summary: PEX26 c.34dupC (p.Leu12ProfsX103) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 3.9e-05 in 206458 control chromosomes (gnomAD). c.34dupC has been reported in the literature in individuals affected with Zellweger Syndrome (Ebberink 2010, Matsumoto 2003). These data indicate that the variant is likely to be associated with disease. Functional studies indicate the variant impedes peroxisomal localization, catalase import, stability and binding to the Pex6p and Pex1p proteins (Furuki 2006). Two ClinVar submissions from clinical diagnostic laboratories (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX26" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017929.5:c.34dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Peroxisome biogenesis disorders, Zellweger syndrome spectrum</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1832200" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1528625" SubmissionDate="2018-03-05" DateLastUpdated="2022-12-11" DateCreated="2018-07-13">
        <ClinVarSubmissionID localKey="NM_017929.5:c.29dupC|MedGen:C3539168" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000784352" DateUpdated="2022-12-11" DateCreated="2018-07-13" Type="SCV" Version="2" SubmitterName="Genomic Research Center, Shahid Beheshti University of Medical Sciences" OrgID="504864" OrganizationCategory="laboratory" OrgAbbreviation="GRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-03-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <GeographicOrigin>Iran</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017929.5:c.29dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3539168" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>WES-Mar 05 2018</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1528626" SubmissionDate="2018-03-05" DateLastUpdated="2022-12-11" DateCreated="2018-07-13">
        <ClinVarSubmissionID localKey="NM_017929.5:c.29dupC|MedGen:C3553951" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000784353" DateUpdated="2022-12-11" DateCreated="2018-07-13" Type="SCV" Version="2" SubmitterName="Genomic Research Center, Shahid Beheshti University of Medical Sciences" OrgID="504864" OrganizationCategory="laboratory" OrgAbbreviation="GRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-03-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <GeographicOrigin>Iran</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017929.5:c.29dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553951" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>WES-Mar 05 2018</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4925255" SubmissionDate="2022-05-18" DateLastUpdated="2023-03-04" DateCreated="2022-05-21">
        <ClinVarSubmissionID localKey="GDXSV:228190" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002513547" DateUpdated="2023-03-04" DateCreated="2022-05-21" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Published functional studies demonstrate significantly reduced catalase activity and defective peroxisomal localization (Furuki S et al., 2006); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 16257970, 12851857)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX26" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:675154</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017929.5:c.34dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_107_20220518054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7856392" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_017929.6:c.34dup|OMIM:614872" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004201503" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_017929.6:c.34dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614872" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Large posterior fontanelle" MappingRef="Preferred">
        <MedGen CUI="C1855233" Name="Large posterior fontanelle" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3966167" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2697801" TraitType="Disease" MappingType="XRef" MappingValue="614873" MappingRef="OMIM">
        <MedGen CUI="C3553951" Name="Peroxisome biogenesis disorder 7B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Abnormal eye morphology" MappingRef="Preferred">
        <MedGen CUI="C4022925" Name="Abnormal eye morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1528626" TraitType="Disease" MappingType="XRef" MappingValue="C3553951" MappingRef="MedGen">
        <MedGen CUI="C3553951" Name="Peroxisome biogenesis disorder 7B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1794602" TraitType="Disease" MappingType="Name" MappingValue="Peroxisome biogenesis disorders, Zellweger syndrome spectrum" MappingRef="Preferred">
        <MedGen CUI="C1832200" Name="Peroxisome biogenesis disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1856269" TraitType="Disease" MappingType="XRef" MappingValue="C3539168" MappingRef="MedGen">
        <MedGen CUI="C3888385" Name="Peroxisome biogenesis disorder 7A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Disease" MappingType="XRef" MappingValue="614872" MappingRef="OMIM">
        <MedGen CUI="C3888385" Name="Peroxisome biogenesis disorder 7A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="22395" TraitType="Disease" MappingType="Name" MappingValue="PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)" MappingRef="Preferred">
        <MedGen CUI="C3888385" Name="Peroxisome biogenesis disorder 7A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Lissencephaly" MappingRef="Preferred">
        <MedGen CUI="C0266463" Name="Lissencephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Wide anterior fontanel" MappingRef="Preferred">
        <MedGen CUI="C1866134" Name="Wide anterior fontanel" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1528625" TraitType="Disease" MappingType="XRef" MappingValue="C3539168" MappingRef="MedGen">
        <MedGen CUI="C3888385" Name="Peroxisome biogenesis disorder 7A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Low-set ears" MappingRef="Preferred">
        <MedGen CUI="C0239234" Name="Low-set ears" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Hypertelorism" MappingRef="Preferred">
        <MedGen CUI="C0020534" Name="Hypertelorism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Oligohydramnios" MappingRef="Preferred">
        <MedGen CUI="C0079924" Name="Oligohydramnios" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of brain morphology" MappingRef="Preferred">
        <MedGen CUI="C4021085" Name="Abnormal brain morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1856269" TraitType="Disease" MappingType="XRef" MappingValue="C3553951" MappingRef="MedGen">
        <MedGen CUI="C3553951" Name="Peroxisome biogenesis disorder 7B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Talipes equinovarus" MappingRef="Preferred">
        <MedGen CUI="C0009081" Name="Clubfoot" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7856392" TraitType="Disease" MappingType="XRef" MappingValue="614872" MappingRef="OMIM">
        <MedGen CUI="C3888385" Name="Peroxisome biogenesis disorder 7A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Abnormality of the face" MappingRef="Preferred">
        <MedGen CUI="C4025871" Name="Abnormality of the face" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Micrognathia" MappingRef="Preferred">
        <MedGen CUI="C0025990" Name="Micrognathia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Micrognathia" MappingRef="Preferred">
        <MedGen CUI="C0025990" Name="Micrognathia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4925255" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1379241" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Seizures" MappingRef="Preferred">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1748190" TraitType="Finding" MappingType="Name" MappingValue="Redundant neck skin" MappingRef="Preferred">
        <MedGen CUI="C1840319" Name="Redundant neck skin" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

